Importance of long-term follow-up after endoscopic management for upper tract urothelial carcinoma and factors leading to surgical management
- PMID: 32157621
- PMCID: PMC7572076
- DOI: 10.1007/s11255-020-02439-5
Importance of long-term follow-up after endoscopic management for upper tract urothelial carcinoma and factors leading to surgical management
Abstract
Purpose: Patients undergoing endoscopic management for upper tract urothelial carcinoma often progress to definitive therapy with radical nephroureterectomy. This study examined the rate of progression as well as risk factors for transitions in treatment over time.
Methods: Retrospective review at two institutions identified patients undergoing endoscopic management for upper tract urothelial carcinoma. Patients were assessed for progression to radical nephroureterectomy. Baseline characteristics were compared using Chi square analysis. Kaplan-Meier method analyzed the probability of patients not progressing to radical nephroureterectomy. Cox proportional hazards identified factors associated with progression to radical nephroureterectomy.
Results: Eighty-one patients had endoscopic management alone and 89 progressed to radical nephroureterectomy. The two groups had similar age, histories of bladder cancer, and Charlson comorbidity index. Positive urinary cytology, ureteroscopic visualization, and biopsy grade were higher in those progressing to RNU (p < 0.001). Hazard modeling demonstrated higher rates of progression to radical nephroureterectomy with positive biopsy (HR 11.8, 95% CI 2.4-59.5, p = 0.003) or visible lesion on ureteroscopy (HR 8.4, 95% CI 3.0-23.9, p < 0.001). Patients with a higher Charlson comorbidity index were less likely to have radical nephroureterectomy. On Kaplan-Meier modeling, the probability of not undergoing radical nephroureterectomy at 2 years and 5 years was 50% and 20%, respectively.
Conclusions: Patients who progress to radical nephroureterectomy after endoscopic management have fewer comorbid conditions and changes in disease status including visible lesions on ureteroscopy and positive biopsies. The high rate of progression to radical nephroureterectomy reinforces the need for long-term follow-up of these patients.
Keywords: Disease progression; Endoscopy; Ureteral neoplasms; Urothelial carcinoma.
Figures
Similar articles
-
The Impact of Upper Tract Urothelial Carcinoma Diagnostic Modality on Intravesical Recurrence after Radical Nephroureterectomy: A Single Institution Series and Updated Meta-Analysis.J Urol. 2021 Sep;206(3):558-567. doi: 10.1097/JU.0000000000001834. Epub 2021 Apr 28. J Urol. 2021. PMID: 33908802
-
Endoscopic versus laparoscopic management of noninvasive upper tract urothelial carcinoma: 20-year single center experience.J Urol. 2013 Jun;189(6):2054-60. doi: 10.1016/j.juro.2012.12.006. Epub 2012 Dec 7. J Urol. 2013. PMID: 23228378
-
Impact of diagnostic ureteroscopy before radical nephroureterectomy on intravesical recurrence in patients with upper tract urothelial cancer.Investig Clin Urol. 2020 Mar;61(2):158-165. doi: 10.4111/icu.2020.61.2.158. Epub 2020 Feb 4. Investig Clin Urol. 2020. PMID: 32158966 Free PMC article.
-
Oncologic Outcomes of Kidney-sparing Surgery Versus Radical Nephroureterectomy for Upper Tract Urothelial Carcinoma: A Systematic Review by the EAU Non-muscle Invasive Bladder Cancer Guidelines Panel.Eur Urol. 2016 Dec;70(6):1052-1068. doi: 10.1016/j.eururo.2016.07.014. Epub 2016 Jul 28. Eur Urol. 2016. PMID: 27477528 Review.
-
Diagnostic Ureteroscopy Prior to Radical Nephroureterectomy for Upper Tract Urothelial Carcinoma Increased the Risk of Intravesical Recurrence.Urol Int. 2018;100(1):92-99. doi: 10.1159/000484417. Epub 2017 Dec 8. Urol Int. 2018. PMID: 29224014 Review.
Cited by
-
Navigating the Aftermath: A Comprehensive Scoping Review on Follow-up Strategies After Kidney-sparing Surgery for Upper Tract Urothelial Carcinoma.Eur Urol Open Sci. 2024 Jul 3;66:82-92. doi: 10.1016/j.euros.2024.06.005. eCollection 2024 Aug. Eur Urol Open Sci. 2024. PMID: 39050911 Free PMC article. Review.
-
Upper Tract Urothelial Cancer: Guideline of Guidelines.Cancers (Basel). 2024 Mar 11;16(6):1115. doi: 10.3390/cancers16061115. Cancers (Basel). 2024. PMID: 38539450 Free PMC article. Review.
-
Upper Tract Urothelial Carcinoma: A Narrative Review of Current Surveillance Strategies for Non-Metastatic Disease.Cancers (Basel). 2023 Dec 20;16(1):44. doi: 10.3390/cancers16010044. Cancers (Basel). 2023. PMID: 38201472 Free PMC article. Review.
-
Advances in chemoablation in upper tract urothelial carcinoma: overview of indications and treatment patterns.Transl Androl Urol. 2023 Sep 30;12(9):1449-1455. doi: 10.21037/tau-23-69. Epub 2023 Aug 1. Transl Androl Urol. 2023. PMID: 37814691 Free PMC article. Review.
-
The importance of second-look ureteroscopy implementation in the conservative management of upper tract urothelial carcinoma.World J Urol. 2023 Oct;41(10):2743-2749. doi: 10.1007/s00345-023-04577-8. Epub 2023 Sep 5. World J Urol. 2023. PMID: 37668716
References
-
- Margulis V, Shariat SF, Matin SF, Kamat AM, Zigeuner R, Kikuchi E, Lotan Y, Weizer A, Raman JD, Wood CG, Upper Tract Urothelial Carcinoma CollaborationThe Upper Tract Urothelial Carcinoma C (2009) Outcomes of radical nephroureterectomy: a series from the Upper Tract Urothelial Carcinoma Collaboration. Cancer 115 (6):1224–1233. doi:10.1002/cncr.24135 - DOI - PubMed
-
- Abouassaly R, Alibhai SMH, Shah N, Timilshina N (2010) Troubling outcomes from population-level analysis of surgery for upper tract urothelial carcinoma. Urology - PubMed
-
- Roupret M, Babjuk M, Comperat E, Zigeuner R, Sylvester RJ, Burger M, Cowan NC, Bohle A, Van Rhijn BWG, Kaasinen E, Palou J, Shariat SF (2015) European Association of Urology Guidelines on Upper Urinary Tract Urothelial Cell Carcinoma: 2015 Update. European urology 68 (5):868–879. doi:10.1016/j.eururo.2015.06.044 - DOI - PubMed
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
